Thus, HO-1 is expressed by LSCs, BMSCs, and leukemic cells of ALL patients and is an ideal target along with vincristine, bendamustine, IM, and HDAC inhibitors. Here, HMOX1 is linked to acute lymphoblastic leukemia.